Stability, accumulation and cytotoxicity of an albumin-cisplatin adduct

Metallomics

Volumn 2, Issue 12, 2010, Pages 811-818

  Møller, Charlotte ^a   Tastesen, Hanne Sørup ^b   Gammelgaard, Bente ^a   Lambert, Ian Henry ^b   Stürup, Stefan ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CIS-PLATIN; EXPOSURE TIME; HUMAN SERUM; MEDIUM EXCHANGE; PHOSPHATE-BUFFERED SALINES; SALINE SOLUTIONS; SEC-ICP-MS; SIZE EXCLUSION; TUMOR CELLS; TUMOR TISSUES;

BODY FLUIDS; CELL DEATH; CYTOTOXICITY; EXPERIMENTS; GEL PERMEATION CHROMATOGRAPHY; INDUCTIVELY COUPLED PLASMA; MASS SPECTROMETRY; PLASMA STABILITY; PLATINUM; SIZE EXCLUSION CHROMATOGRAPHY; TUMORS;

PLATINUM COMPOUNDS;

CISPLATIN; HUMAN SERUM ALBUMIN;

APOPTOSIS; ASCITES CELL; CANCER TISSUE; CONFERENCE PAPER; CYTOTOXICITY; DRUG ACCUMULATION; DRUG STABILITY; PH; PRIORITY JOURNAL; TUMOR CELL;

CELL LINE, TUMOR; CISPLATIN; CYTOTOXINS; HUMANS; METALLOPROTEINS; PLATINUM; SERUM ALBUMIN;

EID: 78650223694     PISSN: 17565901     EISSN: 1756591X     Source Type: Journal    
DOI: 10.1039/c0mt00046a     Document Type: Conference Paper

References (35)

1. B. Michalke Platinum speciation used for elucidating activation or inhibition of Pt-containing anti-cancer drugs J. Trace Elem. Med. Biol. 2010 24 2 69 77
2. D. Esteban-Fernandez E. Moreno-Gordaliza B. Canas M. A. Palacios M. M. Gomez-Gomez Analytical methodologies for metallomics studies of antitumor Pt-containing drugs Metallomics 2010 2 1 19 38
3. X. S. Sun C. N. Tsang H. Z. Sun Identification and characterization of metallodrug binding proteins by (metallo)proteomics Metallomics 2009 1 1 25 31
4. J. Reedijk Metal-Ligand Exchange Kinetics in Platinum and Ruthenium Complexes Significance for Effectiveness as Anticancer Drugs Platinum Met. Rev. 2008 52 1 2 11
5. A. Amin M. A. Buratovich New Platinum and Ruthenium Complexes - the Latest Class of Potential Chemotherapeutic Drugs - a Review of Recent Developments in the Field Mini-Rev. Med. Chem. 2009 9 13 1489 1503
6. J. Reedijk Platinum Anticancer Coordination Compounds: Study of DNA Binding Inspires New Drug Design Eur. J. Inorg. Chem. 2009 10 1303 1312
7. S. J. Lippard and J. M. Berg, Principles of Bioinorganic Chemistry, Iniversity Science Books, Mill Valley, California, U.S, 1994
8. L. W. Seymour Passive Tumor Targeting of Soluble Macromolecules and Drug Conjugates Critical Rev. Therapeutic Drug Carrier Systems 1992 9 2 135 187
9. K. Greish Enhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicines J. Drug Targeting 2007 15 7-8 457 464
10. A. Wunder G. Stehle H. Sinn H. H. Schrenk D. HoffBiederbeck F. Bader E. A. Friedrich P. Peschke W. MaierBorst D. L. Heene Enhanced, albumin uptake by rat tumors Int. J. Oncol. 1997 11 3 497 507
11. C. A. Puckett R. J. Ernst J. K. Barton Exploring the cellular accumulation of metal complexes Dalton Trans. 2010 39 5 1159 1170
12. T. Peters, All About Albumin: Biochemistry, Genetics, and Medical Applications, Elsevier Science & Technology Books, 1st edn, 1996
13. D. N. Bell J. J. Liu M. D. Tingle B. Rattel T. U. Meyer M. J. McKeage Comparative Protein Binding, Stability and Degradation of Satraplatin, Jm118 and Cisplatin in Human Plasma in vitro Clin. Exp. Pharmacol. Physiol. 2008 35 12 1440 1446
14. S. L. Gonias S. V. Pizzo Complexes of serum albumin and cis-dichlorodiammineplatinum(ii). The role of cysteine 34 as a nucleophilic entering group and evidence for reaction between bound platinum and a second macromolecule J. Biol. Chem. 1983 258 9 5764 5769
15. W. C. Cole W. Wolf Preparation and Metabolism of A Cisplatin-Serum Protein Complex Chem.-Biol. Interact. 1980 30 2 223 235
16. K. Takada T. Kawamura M. Inai Y. Yoshikawa O. Ike H. Wada S. Hitomi Irreversible Binding of Cisplatin in Rat Serum Pharm. Pharmacol. Commun. 1999 5 7 449 453
17. K. A. Poulsen E. C. Andersen C. F. Hansen T. K. Klausen C. Hougaard I. H. Lambert E. K. Hoffmann Deregulation of apoptotic volume decrease and ionic movements in multidrug-resistant tumor cells: role of chloride channels Am. J. Physiol.: Cell Physiol. 2010 298 1 C14 C25
18. J. D. Holding W. E. Lindup C. Vanlaer G. C. M. Vreeburg V. Schilling J. A. Wilson P. M. Stell Phase-I Trial of A Cisplatin-Albumin Complex for the Treatment of Cancer of the Head and Neck Br. J. Clin. Pharmacol. 1992 33 1 75 81
19. D. Garmann A. Warnecke G. V. Kalayda F. Kratz U. Jaehde Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells J. Controlled Release 2008 131 2 100 106
20. T. Hoshino M. Misaki M. Yamamoto H. Shimizu Y. Ogawa H. Toguchi In Vitro Cytotoxicities and In Vivo Distribution of Transferrin Platinum(ii) Complex J. Pharm. Sci. 1995 84 2 216 221
21. J. E. Melvik J. M. Dornish E. O. Pettersen The Binding of Cis-Dichlorodiammineplatinum(ii) to Extracellular and Intracellular Compounds in Relation to Drug Uptake and Cytotoxicity Invitro Br. J. Cancer 1992 66 2 260 265
22. H. Schuldes S. Bade J. Knobloch D. Jonas Loss of in vitro cytotoxicity of cisplatin after storage as stock solution in cell culture medium at various temperatures Cancer 1997 79 9 1723 1728
23. R. C. Dolman G. B. Deacon T. W. Hambley Studies of the binding of a series of platinum(iv) complexes to plasma proteins J. Inorg. Biochem. 2002 88 3-4 260 267
24. E. E. M. Brouwers A. D. R. Huitema J. H. M. Schellens J. H. Beijnen The effects of sulfur-containing compounds and gemcitabine on the binding of cisplatin to plasma proteins and DNA determined by inductively coupled plasma mass spectrometry and high performance liquid chromatography-inductively coupled plasma mass spectrometry Anti-Cancer Drugs 2008 19 6 621 630
25. L. Hegedus W. J. F. Vandervijgh I. Klein S. Kerpelfronius H. M. Pinedo Chemical-Reactivity of Cisplatin Bound to Human-Plasma Proteins Cancer Chemother. Pharmacol. 1987 20 3 211 212
26. K. A. Tacka D. Szalda A. K. Souid J. Goodisman J. C. Dabrowiak Experimental and theoretical studies on the pharmacodynamics of cisplatin in Jurkat cells Chem. Res. Toxicol. 2004 17 11 1434 1444
27. A. J. Di Pasqua C. R. Centerwall D. J. Kerwood J. C. Dabrowiak Formation of Carbonato and Hydroxo Complexes in the Reaction of Platinum Anticancer Drugs with Carbonate Inorg. Chem. 2009 48 3 1192 1197
28. J. W. Voss S. F. Pedersen S. T. Christensen I. H. Lambert Regulation of the expression and subcellular localization of the taurine transporter TauT in mouse NIH3T3 fibroblasts Eur. J. Biochem. 2004 271 23-24 4646 4658
29. A. I. Ivanov J. Christodoulou J. A. Parkinson K. J. Barnham A. Tucker J. Woodrow P. J. Sadler Cisplatin binding sites on human albumin J. Biol. Chem. 1998 273 24 14721 14730
30. I. H. L. Hamelers R. W. H. M. Staffhorst J. Voortman B. de Kruijff J. Reedijk P. M. P. V. Henegouwen A. I. P. M. de Kroon High Cytotoxicity of Cisplatin Nanocapsules in Ovarian Carcinoma Cells Depends on Uptake by Caveolae-Mediated Endocytosis Clin. Cancer Res. 2009 15 4 1259 1268
31. M. Q. T. Tran Y. Nygren C. Lundin P. Naredi E. Bjorn Evaluation of cell lysis methods for platinum metallomic studies of human malignant cells Anal. Biochem. 2010 396 1 76 82
32. E. Gabano D. Colangelo A. R. Ghezzi D. Osella The influence of temperature on antiproliferative effects, cellular uptake and DNA platination of the clinically employed Pt(ii)-drugs J. Inorg. Biochem. 2008 102 4 629 635
33. A. E. Egger C. Rappel M. A. Jakupec C. G. Hartinger P. Heffeter B. K. Keppler Development of an experimental protocol for uptake studies of metal compounds in adherent tumor cells J. Anal. At. Spectrom. 2009 24 1 51 61
34. H. S. Tastesen J. B. Holm J. Moller K. A. Poulsen C. Moller S. Sturup E. K. Hoffman I. H. Lambert Pinpointing differences in cisplatin-induced apoptosis in adherent and non-adherent cancer cells Cell Physiol. Biochem.
35. L. N. Nejsum W. J. Nelson Epithelial cell surface polarity: the early steps Front. Biosci. 2009 14 1088 1098